GlaxoSmithKline announced it will ...

GlaxoSmithKline announced it will promptly make clinical trial data forward the use of Paxil in pediatric patients available forward its corporate website. GSK came subject to scrutiny after New York Attorney General Eliot Spitzer filed a lawsuit accusing the company of fraud for failing to reveal negative information about the use of Paxil in children. The released information will include abounding reports of safety and efficacy data from clinical trials, a bibliography of public communications related to these studies, and a alphabetic character to physicians summarizing the